Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine vs Escitalopram for Sexual Functioning in MDD
NCT01364649Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), sponsored by Takeda. Started Jun 2011; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01364649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01364649.